Covid19, SARS-CoV Infection, Thrombocytopenia, Vaccination; Complications, Venous Thrombosis
Conditions
Brief summary
In the context of anti-Covid19 vaccination, atypical thrombosis have occured and potential link with vaccination is under investigation. This study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after antiCovid vaccination.
Detailed description
In the context of anti-Covid19 vaccination, atypical thrombosis have occurred and potential links with vaccination is under investigation. In France, the study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after anti-Covid vaccination.
Interventions
OTHERRetrospective data and biological samples
Analysis of data and biological samples collected during hospitalization:
Sponsors
University Hospital, Lille
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
atypical thrombosis symptoms onset within 4 weeks of vaccination
Exclusion criteria
children
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional outcome (modified rankin scale) | through study completion, an average of 1 years |
Secondary
| Measure | Time frame |
|---|---|
| Recurrent vascular events | through study completion, an average of 1 years |
| Mortality | through study completion, an average of 1 years |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORCharlotte Cordonnier, MD,PhD
University Hospital, Lille
Outcome results
None listed